ALT - Altimmune - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALT is currently covered by 6 analysts with an average price target of $19.15. This is a potential upside of $12.5 (187.97%) from yesterday's end of day stock price of $6.65.

Altimmune's activity chart (see below) currently has 61 price targets and 73 ratings on display. The stock rating distribution of ALT is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.98% with an average time for these price targets to be met of 35.1 days.

Highest price target for ALT is $25, Lowest price target is $12, average price target is $19.15.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 05-Feb-2025. First documented stock forecast 01-Jun-2020.

Currently out of the existing stock ratings of ALT, 22 are a BUY (91.67%), 2 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$5.58 (86.92%)

$12

26 days ago
(05-Feb-2025)

0/14 (0%)

$5.01 (71.67%)

Buy

$20

$13.58 (211.53%)

$20

6 months 19 days ago
(12-Aug-2024)

4/16 (25%)

$13.78 (221.54%)

214

Buy

$25

$18.58 (289.41%)

$25

8 months 10 days ago
(21-Jun-2024)

3/14 (21.43%)

$18.59 (290.02%)

42

Buy

$24

$17.58 (273.83%)

$16

9 months 21 days ago
(10-May-2024)

0/13 (0%)

$16.78 (232.41%)

Hold

$26

10 months 2 days ago
(29-Apr-2024)

0/6 (0%)

$12.36 (90.62%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALT (Altimmune) average time for price targets to be met?

On average it took 35.1 days on average for the stock forecasts to be realized with a an average price target met ratio 12.98

Which analyst has the current highest performing score on ALT (Altimmune) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on ALT (Altimmune)?

Mayank Mamtani works at B. RILEY and has 8 price targets and 5 ratings on ALT

Which analyst is the currently most bullish on ALT (Altimmune)?

Roger Song with highest potential upside - $28.34

Which analyst is the currently most reserved on ALT (Altimmune)?

Kelechi Chikere with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?